TMCI Q2 2024 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena

TMCITreace Medical Concepts, Inc.

$104M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$44M+6.0% YoY

Gross Profit

$36M80.2% margin

Operating Income

-$21M-48.1% margin

Net Income

-$21M-47.7% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-13.0%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$16M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$226M

Total Liabilities

$114M

Stockholders' Equity

$112M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$42M	+6.0%
Gross Profit	$36M	$34M	+4.1%
Operating Income	-$21M	-$13M	-63.8%
Net Income	-$21M	-$12M	-72.8%